ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an i...

FDA Recall #Z-1312-2018 — Class II — December 18, 2017

Recall #Z-1312-2018 Date: December 18, 2017 Classification: Class II Status: Terminated

Product Description

ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. To be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.

Reason for Recall

The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.

Recalling Firm

Phadia US Inc — Portage, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

950 total

Distribution

Nationwide Distribution

Code Information

Lots 990DS, Exp 2017.12.31 990DT, Exp 2018.01.31 990DW, Exp 2018.03.31 990DX, Exp, 2018.05.31 990DY

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated